49 results
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
one member of the Board of Directors qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules
8-K
EX-1.1
lbf64 nmh98ayfh75yun
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
S-8
sikhidhyeq1z2lr
19 Jan 21
Registration of securities for employees
12:00am
8-K
EX-1.1
2hn q7pyeh
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
8-K
EX-99.1
dooi5
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm
8-K
EX-5.1
weql85a
27 Mar 20
Other Events
12:53pm
8-K
EX-5.1
n1n2n x3fauyn7f64g3k
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
8-K
ogaa9xf 7rzndmn
6 Jan 20
Hepion Pharmaceuticals Announces Publication inExpert Opinion on Investigational Drugs
4:23pm